🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.

Experimental Treatment Gaining Popularity Online

The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to message these accounts directly for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where communities with numerous of participants share comparison photos, administration instructions and claims of rapid British shipping. Sellers promote the substance there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.

Several professionals stated the popularity for retatrutide could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.

Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, prosecution or prison.

Service Response and Content Elimination

Based on TikTok, the platform has removed problematic content and prohibited related hashtags and search suggestions. The company said it was dedicated to keeping the platform safe and investing in enhancing enforcement strategies.

Digital Marketplace Operations

Research also found communities with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of users, filled with images of slimming results, positive testimonials and step-by-step guides for preparing or administering at residence.

Within moments of entering one community, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor sent an guidebook and guaranteed shipping within two days. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Item Information and Costs

Within these communities, posts display black plastic packages with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with sterile water, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how long a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram said it actively monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they can’t verify. Although the research behind retatrutide is sound, these digital products may not include what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are highly risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her team has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a company experimental product not yet authorized … may expose patients to possibly significant health risks”.